ATE535544T1 - Verfahren zur verhinderung von polymeren des humanen serumalbumins - Google Patents

Verfahren zur verhinderung von polymeren des humanen serumalbumins

Info

Publication number
ATE535544T1
ATE535544T1 AT01978882T AT01978882T ATE535544T1 AT E535544 T1 ATE535544 T1 AT E535544T1 AT 01978882 T AT01978882 T AT 01978882T AT 01978882 T AT01978882 T AT 01978882T AT E535544 T1 ATE535544 T1 AT E535544T1
Authority
AT
Austria
Prior art keywords
human serum
preventing human
aluminum polymers
serum aluminum
serum albumin
Prior art date
Application number
AT01978882T
Other languages
English (en)
Inventor
Satoshi Adachi
Hiroshi Mizokami
Yoshitaka Tajima
Yoshinobu Miyatsu
Toshinobu Nouchi
Yoshitaka Ushio
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE535544T1 publication Critical patent/ATE535544T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01978882T 2000-10-24 2001-10-24 Verfahren zur verhinderung von polymeren des humanen serumalbumins ATE535544T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000324029A JP4798832B2 (ja) 2000-10-24 2000-10-24 ヒト血清アルブミン多量体の除去方法
PCT/JP2001/009335 WO2002034786A1 (en) 2000-10-24 2001-10-24 Method of eliminating human serum albumin polymers

Publications (1)

Publication Number Publication Date
ATE535544T1 true ATE535544T1 (de) 2011-12-15

Family

ID=18801620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978882T ATE535544T1 (de) 2000-10-24 2001-10-24 Verfahren zur verhinderung von polymeren des humanen serumalbumins

Country Status (11)

Country Link
US (1) US7001885B2 (de)
EP (1) EP1329461B8 (de)
JP (1) JP4798832B2 (de)
KR (1) KR100847883B1 (de)
CN (1) CN1406245B (de)
AT (1) ATE535544T1 (de)
AU (1) AU783871B2 (de)
CA (1) CA2395589C (de)
DK (1) DK1329461T3 (de)
ES (1) ES2373035T3 (de)
WO (1) WO2002034786A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
ATE331735T1 (de) * 2000-10-24 2006-07-15 Chemo Sero Therapeut Res Inst Verfahren zur monomerisierung von humanen serumalbumin-polymeren
SE526227C2 (sv) * 2002-05-15 2005-08-02 North China Pharmaceutical Group Metod för rening av rekombinant humant serumalbumin
JPWO2005004902A1 (ja) * 2003-07-10 2006-08-24 ニプロ株式会社 プラスチック容器入り組換えヒト血清アルブミン製剤
FR2866890B1 (fr) * 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
CN102190722B (zh) * 2010-03-16 2014-03-26 上海欣瑞特生物医药技术有限公司 一种纯化重组人血白蛋白的方法
KR101595151B1 (ko) * 2012-01-31 2016-02-18 이화여자대학교 산학협력단 일산화질소에 의해 형성되는 알부민 다량체 및 알부민 구조변형체
US20140186447A1 (en) * 2012-12-28 2014-07-03 Abraxis Bioscience, Llc Nanoparticle compositions of albumin and paclitaxel
US10527604B1 (en) 2015-03-05 2020-01-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
US10705070B1 (en) 2015-03-05 2020-07-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
EP3429345B1 (de) 2016-10-04 2019-09-11 Albumedix Ltd. Verwendungen von rekombinantem, von hefe abgeleitetem serumalbumin
CN107216383A (zh) * 2017-07-13 2017-09-29 同路生物制药有限公司 一种人血白蛋白的制备方法及该人血白蛋白
WO2021086946A1 (en) 2019-10-28 2021-05-06 Abraxis Bioscience, Llc Pharmaceutical compositions of albumin and rapamycin
US20230000774A1 (en) 2019-12-04 2023-01-05 Albumedix Limited Methods and compositions produced thereby
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
CN116744984A (zh) 2020-12-28 2023-09-12 达沃有限公司 包含蛋白质和多官能化改性的基于聚乙二醇的交联剂的反应性干粉状止血材料

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169829A (en) 1972-07-05 1979-10-02 Institut Merieux Process for the preparation of purified albumin and albumin obtained by said process
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US4705848A (en) * 1986-06-02 1987-11-10 International Minerals & Chemical Corp. Isolation of bioactive, monomeric growth hormone
IL88326A (en) 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
JP2926722B2 (ja) 1988-10-20 1999-07-28 吉富製薬株式会社 アルブミン製剤及びその製造方法
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
JPH0671434B2 (ja) 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH04234326A (ja) * 1990-12-27 1992-08-24 Green Cross Corp:The アルブミン製剤及びその製法
JPH0671434A (ja) 1991-05-30 1994-03-15 Tadahiro Omi クリーンチャンバーの溶接方法
JPH07102148B2 (ja) * 1992-05-20 1995-11-08 株式会社ミドリ十字 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JP3508149B2 (ja) * 1993-02-25 2004-03-22 三菱ウェルファーマ株式会社 ヒト血清アルブミンおよびその製造方法
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
JPH07126182A (ja) 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
DE69434126T3 (de) * 1993-12-17 2009-07-09 Mitsubishi Pharma Corp. Verfahren zum Entfärben von menschlichemn Serum-Albumin
JP3702474B2 (ja) * 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
JP3840674B2 (ja) 1994-08-31 2006-11-01 三菱ウェルファーマ株式会社 遺伝子操作に由来するヒト血清アルブミンの精製方法
ES2228052T3 (es) * 1998-06-01 2005-04-01 Genentech, Inc. Separacion demonomeros de anticuerpos de sus multimeros utilizando cromatografia de intercambio de iones.

Also Published As

Publication number Publication date
JP4798832B2 (ja) 2011-10-19
KR20020065608A (ko) 2002-08-13
EP1329461B1 (de) 2011-11-30
US7001885B2 (en) 2006-02-21
AU783871B2 (en) 2005-12-15
CN1406245B (zh) 2010-05-26
EP1329461A1 (de) 2003-07-23
AU1093502A (en) 2002-05-06
JP2002128795A (ja) 2002-05-09
US20020183492A1 (en) 2002-12-05
ES2373035T3 (es) 2012-01-30
CA2395589A1 (en) 2002-05-02
EP1329461A4 (de) 2004-12-01
DK1329461T3 (da) 2012-01-30
CN1406245A (zh) 2003-03-26
EP1329461B8 (de) 2012-03-14
CA2395589C (en) 2012-08-28
WO2002034786A1 (en) 2002-05-02
KR100847883B1 (ko) 2008-07-23

Similar Documents

Publication Publication Date Title
ATE535544T1 (de) Verfahren zur verhinderung von polymeren des humanen serumalbumins
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE69435266D1 (de) Methode zur Detektion von Luftblasen
DE69628564D1 (de) Verfahren zur reinigung von viren mit chromatographie
DE69735295D1 (de) Verfahren zur Aufkonzentrierung von Antikörperlösungen
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
ATE42206T1 (de) Verfahren und zusammensetzung zur gleichzeitigen reinigung und desinfektion von kontaktlinsen.
EP1450816A4 (de) Verfahren zur behandlung von störungen im zusammenhang mit erhöhter cholesterinkonzentration
DE69004101D1 (de) Verfahren zur kristallisation von enzymen.
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DE69513027D1 (de) Verfahren zur bestimmung des präthrombotischen status
DE69623191D1 (de) Verfahren zur Konzentration von saurem Phospholipid
SE9404141D0 (sv) New buffer system for electrophoresis
DE69419207D1 (de) Vorrichtung zur Feststellung der Konzentration von verschiedenen Ionen in wässerigen Lösungen
DE69021729D1 (de) Verfahren zur gewinnung von natürlich hergestelltem chymosin.
DE60100565D1 (de) Verfahren zur Reinigung von Phosphatidylserin
DE60239329D1 (de) Verwendung von lanthankarbonat zur prävention von nierensteinleiden
DE69232662D1 (de) Verfahren zur wirkungsverstärkung von mitteln der ersten wahl bei der behandlung mehrfachresistenter zellen
DE60234811D1 (de) Verfahren und zusammensetzungen zur extraktion von proteinen aus zellen
ATE149514T1 (de) Verfahren zur reaktivierung von denaturiertem protein
DE59105092D1 (de) Verfahren zur extraktiven Trennung von L-Phosphinothricin und L-Glutaminsäure in wässriger Lösung.
DE69400672D1 (de) Verfahren zur Verminderung des Verunreinigungsniveaus in wässrigen Monomerenlösungen
DE69618536D1 (de) Verfahren zur Inaktivierung von Viren in Proteinen
DE69938827D1 (de) Verwendung von inhibitoren von asparaginyl-endopeptidase aus säugetieren zur modulierung des immunsystemen
DE50113517D1 (de) Verfahren zur prognose des kumulativen überlebens von patienten